MIT Seeks To Exit Max Planck RNA Patent Suit

By Ryan Davis

Law360, New York (February 26, 2010, 2:04 PM ET) -- The Massachusetts Institute of Technology and the Max Planck Institute have filed a joint motion to dismiss the university from Max Planck's suit over RNA interference patents, following MIT's agreement to be bound by any declaratory judgment against its co-defendants.

The motion, filed Thursday in the U.S. District Court for the District of Massachusetts, stresses that the case remains pending against the other defendants, the University of Massachusetts and the Whitehead Institute for Biomedical Research.

According to the motion, MIT shall be bound by any equitable...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles